ĐÁNH GIÁ KẾT QUẢ PHẪU THUẬT UNG THƯ TUYẾN GIÁP TẠI BỆNH VIỆN TAI MŨI HỌNG TRUNG ƯƠNG GIAI ĐOẠN 06/2020–06/2025

Abstract

Objective: To evaluate the surgical outcomes of thyroid cancer treatment at the National Ear, Nose and Throat Hospital from June 2020 to June 2025. Methods: A cross-sectional descriptive study was conducted on 139 patients with thyroid cancer who underwent surgery at the National ENT Hospital. Results: The mean age was 44 years. Females accounted for 82.7%, males 17.3%. The most common presenting symptom was a neck mass (69.8%). On ultrasound, 90.6% of tumors were hypoechoic, and tumors < 2 cm accounted for 85.6%. The most common tumor location was the right lobe (56.8%). Cervical lymph node metastases were found clinically in 28.8%. Total thyroidectomy was performed in 78.4% of cases, and lymph node dissection in 68.3%. Stage I accounted for 72.7%, stage II for 18.7%, stage III for 7.9%, and stage IVa for 0.7%. Postoperative complications included transient hypoparathyroidism (12.2%) and hoarseness (5.8%). Recurrence occurred in 5% of patients, all in cervical lymph nodes, mainly within 6 months after surgery. Conclusion: Surgical treatment of thyroid cancer at the National ENT Hospital was safe, with a low complication rate, and most patients were diagnosed at an early stage.